Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J H van Deventer

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Gut|August 13, 2002
Anti-tumour necrosis factor therapy in Crohn's disease: where are we now?S J H van Deventer
Best Practice & Research. Clinical Gastroenterology|March 6, 2003
New biological therapies in inflammatory bowel diseaseS J H van Deventer
Best Practice & Research. Clinical Gastroenterology|December 11, 2002
Taming the mucosal immune response in Crohn's diseaseS J H van Deventer
Gut|June 22, 2002
A place for TACES J H van Deventer
Gut|April 16, 2002
Small therapeutic molecules for the treatment of inflammatory bowel diseaseS J H van Deventer
Inflammatory Bowel Diseases|July 20, 2002
The future of inflammatory bowel disease therapyS J H van Deventer
Best Practice & Research. Clinical Gastroenterology|May 5, 2004
Endoscopic treatment of strictures in Crohn's diseaseG W Erkelens, S J H van Deventer
Gut|October 14, 2004
T cell apoptosis and inflammatory bowel diseaseM P Peppelenbosch, S J H van Deventer
The Netherlands Journal of Medicine|July 11, 2003
Infliximab therapy in Crohn's disease: safety issuesD W Hommes, S J H van Deventer
Gut|October 14, 2004
A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitisS J H van Deventer, J A Tami, M K Wedel
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Gut|August 13, 2002
Anti-tumour necrosis factor therapy in Crohn's disease: where are we now?S J H van Deventer
Best Practice & Research. Clinical Gastroenterology|March 6, 2003
New biological therapies in inflammatory bowel diseaseS J H van Deventer
Best Practice & Research. Clinical Gastroenterology|December 11, 2002
Taming the mucosal immune response in Crohn's diseaseS J H van Deventer
Gut|June 22, 2002
A place for TACES J H van Deventer
Gut|April 16, 2002
Small therapeutic molecules for the treatment of inflammatory bowel diseaseS J H van Deventer
Inflammatory Bowel Diseases|July 20, 2002
The future of inflammatory bowel disease therapyS J H van Deventer
Best Practice & Research. Clinical Gastroenterology|May 5, 2004
Endoscopic treatment of strictures in Crohn's diseaseG W Erkelens, S J H van Deventer
Gut|October 14, 2004
T cell apoptosis and inflammatory bowel diseaseM P Peppelenbosch, S J H van Deventer
The Netherlands Journal of Medicine|July 11, 2003
Infliximab therapy in Crohn's disease: safety issuesD W Hommes, S J H van Deventer
Gut|October 14, 2004
A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitisS J H van Deventer, J A Tami, M K Wedel
Pageof 3